Reuters logo
BRIEF-GLG Pharma signs contract with IQ Pharma for realization of TNBC Project
October 17, 2017 / 7:57 AM / a month ago

BRIEF-GLG Pharma signs contract with IQ Pharma for realization of TNBC Project

Oct 17 (Reuters) - GLG Pharma SA:

* SAID ON MONDAY IT SIGNED AGREEMENT WITH IQ PHARMA SA FOR REALIZATION OF TNBC PROJECT

* AGREEMENT SIGNED FOR PHASE I(OPTIMAL THERAPEUTIC DOSE) AND II (DETERMINATION OF EFFICACY) CLINICAL TRIALS FOR THERAPY WITH AN INNOVATIVE STAT-3 INHIBITOR IN ORAL FORM IN PATIENTS WITH DIAGNOSED TRIPLE NEGATIVE BREAST CANCER (TNBC)

* SUBJECT OF THE CONTRACT WILL BE IMPLEMENTED UNTIL DEC 31, 2018

* REMUNERATION FOR IQ PHARMA AMOUNTS TO 4.6 MILLION ZLOTYS GROSS

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below